Tapewire

NYSE · USD

EDVA

Endovia Health Sciences, Inc.

Export transactions ↓
Tapewire entity
8508
SEC CIK
0001553788
Parsed reports
63

Last 12 months

Inside the activity.

0 purchase rows · 0 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202500
Dec 202500
Jan 202600
Feb 202600
Mar 202600
Apr 202600
May 202600
Jun 202600
Jul 202600
Aug 202600
Sep 202600
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
June 08, 2026 Filed Jun 10, 2026 20:31 UTC GrantStock Options (Right to Buy) · Derivative 500,000 Not disclosed Strike: $0.25 Not disclosed
Disclosure

SEC source: 0001731122-26-000834 · ownership.xml · derivative · entry 1

Francis Knuettel II · CIK 0001433316 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 500,000

Underlying: Common Stock · 500,000 shares

Expires 2036-06-08

F1 · security: The grant of the Issuer's non-qualified stock options was exempt from Section 16(b) of the Securities Exchange Act of 1934 by virtue of Rule 16b-3 promulgated thereunder, as it was approved by the Issuer's Board of Directors. The options were granted under the Issuer's 2025 Equity Incentive Plan, and the exercisability of the options is subject to execution of the Issuer's standard form of Stock Option Agreement. The options are fully vested.

F1 · price: The grant of the Issuer's non-qualified stock options was exempt from Section 16(b) of the Securities Exchange Act of 1934 by virtue of Rule 16b-3 promulgated thereunder, as it was approved by the Issuer's Board of Directors. The options were granted under the Issuer's 2025 Equity Incentive Plan, and the exercisability of the options is subject to execution of the Issuer's standard form of Stock Option Agreement. The options are fully vested.

F1 · derivative.exercise_date: The grant of the Issuer's non-qualified stock options was exempt from Section 16(b) of the Securities Exchange Act of 1934 by virtue of Rule 16b-3 promulgated thereunder, as it was approved by the Issuer's Board of Directors. The options were granted under the Issuer's 2025 Equity Incentive Plan, and the exercisability of the options is subject to execution of the Issuer's standard form of Stock Option Agreement. The options are fully vested.

Read SEC document
June 08, 2026 Filed Jun 10, 2026 20:31 UTC
Scott Martin PInterim CFO
GrantStock Options (Right to Buy) · Derivative 700,000 Not disclosed Strike: $0.25 Not disclosed
Disclosure

SEC source: 0001731122-26-000832 · ownership.xml · derivative · entry 1

Scott Martin P · CIK 0001306996 · Interim CFO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 700,000

Underlying: Common Stock · 700,000 shares

Expires 2036-06-08

F1 · security: The grant of the Issuer's non-qualified stock options was exempt from Section 16(b) of the Securities Exchange Act of 1934 by virtue of Rule 16b-3 promulgated thereunder, as it was approved by the Issuer's Board of Directors. The options were granted under the Issuer's 2025 Equity Incentive Plan and the exercisability of the options is subject to execution of the Issuer's standard form of Stock Option Agreement. The options are fully vested.

F1 · price: The grant of the Issuer's non-qualified stock options was exempt from Section 16(b) of the Securities Exchange Act of 1934 by virtue of Rule 16b-3 promulgated thereunder, as it was approved by the Issuer's Board of Directors. The options were granted under the Issuer's 2025 Equity Incentive Plan and the exercisability of the options is subject to execution of the Issuer's standard form of Stock Option Agreement. The options are fully vested.

F1 · derivative.exercise_date: The grant of the Issuer's non-qualified stock options was exempt from Section 16(b) of the Securities Exchange Act of 1934 by virtue of Rule 16b-3 promulgated thereunder, as it was approved by the Issuer's Board of Directors. The options were granted under the Issuer's 2025 Equity Incentive Plan and the exercisability of the options is subject to execution of the Issuer's standard form of Stock Option Agreement. The options are fully vested.

Read SEC document
June 08, 2026 Filed Jun 10, 2026 20:31 UTC GrantStock Options (Right to Buy) · Derivative 500,000 Not disclosed Strike: $0.25 Not disclosed
Disclosure

SEC source: 0001731122-26-000836 · ownership.xml · derivative · entry 1

Fore Thomas Butler · CIK 0001715594 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 500,000

Underlying: Common Stock · 500,000 shares

Expires 2036-06-08

F1 · security: The grant of the Issuer's non-qualified stock options was exempt from Section 16(b) of the Securities Exchange Act of 1934 by virtue of Rule 16b-3 promulgated thereunder, as it was approved by the Issuer's Board of Directors. The options were granted under the Issuer's 2025 Equity Incentive Plan and the exercisability of the options is subject to execution of the Issuer's standard form of Stock Option Agreement. The options are fully vested.

F1 · price: The grant of the Issuer's non-qualified stock options was exempt from Section 16(b) of the Securities Exchange Act of 1934 by virtue of Rule 16b-3 promulgated thereunder, as it was approved by the Issuer's Board of Directors. The options were granted under the Issuer's 2025 Equity Incentive Plan and the exercisability of the options is subject to execution of the Issuer's standard form of Stock Option Agreement. The options are fully vested.

F1 · derivative.exercise_date: The grant of the Issuer's non-qualified stock options was exempt from Section 16(b) of the Securities Exchange Act of 1934 by virtue of Rule 16b-3 promulgated thereunder, as it was approved by the Issuer's Board of Directors. The options were granted under the Issuer's 2025 Equity Incentive Plan and the exercisability of the options is subject to execution of the Issuer's standard form of Stock Option Agreement. The options are fully vested.

Read SEC document
June 08, 2026 Filed Jun 10, 2026 20:31 UTC GrantStock Options (Right to Buy) · Derivative 500,000 Not disclosed Strike: $0.25 Not disclosed
Disclosure

SEC source: 0001731122-26-000835 · ownership.xml · derivative · entry 1

Caple Frederick William · CIK 0001978199 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 500,000

Underlying: Common Stock · 500,000 shares

Expires 2036-06-08

F1 · security: The grant of the Issuer's non-qualified stock options was exempt from Section 16(b) of the Securities Exchange Act of 1934 by virtue of Rule 16b-3 promulgated thereunder, as it was approved by the Issuer's Board of Directors. The options were granted under the Issuer's 2025 Equity Incentive Plan and the exercisability of the options is subject to execution of the Issuer's standard form of Stock Option Agreement. The options are fully vested.

F1 · price: The grant of the Issuer's non-qualified stock options was exempt from Section 16(b) of the Securities Exchange Act of 1934 by virtue of Rule 16b-3 promulgated thereunder, as it was approved by the Issuer's Board of Directors. The options were granted under the Issuer's 2025 Equity Incentive Plan and the exercisability of the options is subject to execution of the Issuer's standard form of Stock Option Agreement. The options are fully vested.

F1 · derivative.exercise_date: The grant of the Issuer's non-qualified stock options was exempt from Section 16(b) of the Securities Exchange Act of 1934 by virtue of Rule 16b-3 promulgated thereunder, as it was approved by the Issuer's Board of Directors. The options were granted under the Issuer's 2025 Equity Incentive Plan and the exercisability of the options is subject to execution of the Issuer's standard form of Stock Option Agreement. The options are fully vested.

Read SEC document
June 08, 2026 Filed Jun 10, 2026 20:31 UTC
Cobb Brady JamesDirector · Interim CEO
GrantStock Options (Right to Buy) · Derivative 925,000 Not disclosed Strike: $0.25 Not disclosed
Disclosure

SEC source: 0001731122-26-000833 · ownership.xml · derivative · entry 1

Cobb Brady James · CIK 0002112459 · Director · Interim CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 925,000

Underlying: Common Stock · 925,000 shares

Expires 2036-06-08

F1 · security: The grant of the Issuer's non-qualified stock options was exempt from Section 16(b) of the Securities Exchange Act of 1934 by virtue of Rule 16b-3 promulgated thereunder, as it was approved by the Issuer's Board of Directors. The options were granted under the Issuer's 2025 Equity Incentive Plan and the exercisability of the options is subject to execution of the Issuer's standard form of Stock Option Agreement. The options are fully vested.

F1 · price: The grant of the Issuer's non-qualified stock options was exempt from Section 16(b) of the Securities Exchange Act of 1934 by virtue of Rule 16b-3 promulgated thereunder, as it was approved by the Issuer's Board of Directors. The options were granted under the Issuer's 2025 Equity Incentive Plan and the exercisability of the options is subject to execution of the Issuer's standard form of Stock Option Agreement. The options are fully vested.

F1 · derivative.exercise_date: The grant of the Issuer's non-qualified stock options was exempt from Section 16(b) of the Securities Exchange Act of 1934 by virtue of Rule 16b-3 promulgated thereunder, as it was approved by the Issuer's Board of Directors. The options were granted under the Issuer's 2025 Equity Incentive Plan and the exercisability of the options is subject to execution of the Issuer's standard form of Stock Option Agreement. The options are fully vested.

Read SEC document
June 08, 2026 Filed Jun 15, 2026 20:30 UTC
Bondurant Michael BreenChief Operating Officer
GrantStock Options (Right to Buy) · Derivative 800,000 Not disclosed Strike: $0.25 Not disclosed
Disclosure

SEC source: 0001731122-26-000860 · ownership.xml · derivative · entry 1

Bondurant Michael Breen · CIK 0002140335 · Chief Operating Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 800,000

Underlying: Common Stock · 800,000 shares

Expires 2036-06-08

F1 · security: The grant of the Issuer's non-qualified stock options was exempt from Section 16(b) of the Securities Exchange Act of 1934 by virtue of Rule 16b-3 promulgated thereunder, as it was approved by the Issuer's Board of Directors. The options were granted under the Issuer's 2025 Equity Incentive Plan and the exercisability of the options is subject to execution of the Issuer's standard form of Stock Option Agreement. The options are fully vested.

F1 · price: The grant of the Issuer's non-qualified stock options was exempt from Section 16(b) of the Securities Exchange Act of 1934 by virtue of Rule 16b-3 promulgated thereunder, as it was approved by the Issuer's Board of Directors. The options were granted under the Issuer's 2025 Equity Incentive Plan and the exercisability of the options is subject to execution of the Issuer's standard form of Stock Option Agreement. The options are fully vested.

F1 · derivative.exercise_date: The grant of the Issuer's non-qualified stock options was exempt from Section 16(b) of the Securities Exchange Act of 1934 by virtue of Rule 16b-3 promulgated thereunder, as it was approved by the Issuer's Board of Directors. The options were granted under the Issuer's 2025 Equity Incentive Plan and the exercisability of the options is subject to execution of the Issuer's standard form of Stock Option Agreement. The options are fully vested.

Read SEC document
July 31, 2025 Filed Oct 10, 2025 16:31 UTC
Devereux William TChief Financial Officer
GrantWarrants · Derivative 1,000,000 Not disclosed Strike: $0.80 Not disclosed
Disclosure

SEC source: 0001731122-25-001372 · ownership.xml · derivative · entry 1

Devereux William T · CIK 0002089296 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,000,000

Underlying: Common Stock · 1,000,000 shares

Expires 2030-07-31

F1 · security: The grant of the Issuer's warrants was exempt from Section 16(b) of the Securities Exchange Act of 1934 by virtue of Rule 16b-3 promulgated thereunder, as it was approved by the Issuer's Board of Directors. The warrants are fully vested.

F1 · price: The grant of the Issuer's warrants was exempt from Section 16(b) of the Securities Exchange Act of 1934 by virtue of Rule 16b-3 promulgated thereunder, as it was approved by the Issuer's Board of Directors. The warrants are fully vested.

Read SEC document
July 31, 2025 Filed Oct 14, 2025 16:15 UTC
Meissner William R.President and CMO · 10% owner
GrantWarrants · Derivative 750,000 Not disclosed Strike: $0.80 Not disclosed
Disclosure

SEC source: 0001731122-25-001374 · ownership.xml · derivative · entry 1

Meissner William R. · CIK 0001489090 · President and CMO · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 750,000

Underlying: Common Stock · 750,000 shares

Expires 2030-07-31

F1 · security: The grant of the Issuer's warrants was exempt from Section 16(b) of the Securities Exchange Act of 1934 by virtue of Rule 16b-3 promulgated thereunder, as it was approved by the Issuer's Board of Directors. The warrants are fully vested.

F1 · price: The grant of the Issuer's warrants was exempt from Section 16(b) of the Securities Exchange Act of 1934 by virtue of Rule 16b-3 promulgated thereunder, as it was approved by the Issuer's Board of Directors. The warrants are fully vested.

Read SEC document
July 31, 2025 Filed Oct 15, 2025 20:16 UTC GrantWarrants · Derivative 750,000 Not disclosed Strike: $0.80 Not disclosed
Disclosure

SEC source: 0001731122-25-001383 · ownership.xml · derivative · entry 1

Yorke Justin W · CIK 0001361896 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 750,000

Underlying: Common Stock · 750,000 shares

Expires 2030-07-31

F1 · security: The grant of the Issuer's warrants was exempt from Section 16(b) of the Securities Exchange Act of 1934 by virtue of Rule 16b-3 promulgated thereunder, as it was approved by the Issuer's Board of Directors. The warrants are fully vested.

F1 · price: The grant of the Issuer's warrants was exempt from Section 16(b) of the Securities Exchange Act of 1934 by virtue of Rule 16b-3 promulgated thereunder, as it was approved by the Issuer's Board of Directors. The warrants are fully vested.

Read SEC document
July 31, 2025 Filed Oct 15, 2025 20:20 UTC
Nistico RobertDirector · CEO and Chairman · 10% owner
GrantWarrants · Derivative 750,000 Not disclosed Strike: $0.80 Not disclosed
Disclosure

SEC source: 0001731122-25-001386 · ownership.xml · derivative · entry 1

Nistico Robert · CIK 0001797597 · Director · CEO and Chairman · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 750,000

Underlying: Common Stock · 750,000 shares

Expires 2030-07-31

F1 · security: The grant of the Issuer's warrants was exempt from Section 16(b) of the Securities Exchange Act of 1934 by virtue of Rule 16b-3 promulgated thereunder, as it was approved by the Issuer's Board of Directors. The warrants shall vest as follows: one third upon completion of the repayment by the Company of the UpTime Investors and the other two thirds vesting quarterly over a two-year period with the first vesting date on October 31, 2025.

F1 · price: The grant of the Issuer's warrants was exempt from Section 16(b) of the Securities Exchange Act of 1934 by virtue of Rule 16b-3 promulgated thereunder, as it was approved by the Issuer's Board of Directors. The warrants shall vest as follows: one third upon completion of the repayment by the Company of the UpTime Investors and the other two thirds vesting quarterly over a two-year period with the first vesting date on October 31, 2025.

Read SEC document
July 31, 2025 Filed Oct 20, 2025 20:20 UTC
Caple Frederick WilliamDirector · 10% owner
GrantWarrants · Derivative 750,000 Not disclosed Strike: $0.80 Not disclosed
Disclosure

SEC source: 0001731122-25-001406 · ownership.xml · derivative · entry 1

Caple Frederick William · CIK 0001978199 · Director · 10% owner

10b5-1 filing: No plan indicated

Ownership: Indirect · SNS Universal Solutions LLC

Disclosed balance after: 750,000

Underlying: Common Stock · 750,000 shares

Expires 2030-07-31

F1 · security: The grant of the Issuer's warrants was exempt from Section 16(b) of the Securities Exchange Act of 1934 by virtue of Rule 16b-3 promulgated thereunder, as it was approved by the Issuer's Board of Directors. The warrants are fully vested.

F1 · price: The grant of the Issuer's warrants was exempt from Section 16(b) of the Securities Exchange Act of 1934 by virtue of Rule 16b-3 promulgated thereunder, as it was approved by the Issuer's Board of Directors. The warrants are fully vested.

F2 · ownership.nature: SNS Universal Solutions LLC is an entity which the Reporting Person controls.

Read SEC document
July 31, 2025 Filed Oct 31, 2025 20:15 UTC
Fore Thomas ButlerDirector · 10% owner
GrantWarrants · Derivative 750,000 Not disclosed Strike: $0.80 Not disclosed
Disclosure

SEC source: 0001731122-25-001461 · ownership.xml · derivative · entry 1

Fore Thomas Butler · CIK 0001715594 · Director · 10% owner

10b5-1 filing: No plan indicated

Ownership: Indirect · By TBF Holdings LLC

Disclosed balance after: 750,000

Underlying: Common Stock · 750,000 shares

Expires 2030-07-31

F1 · security: The grant of the Issuer's warrants was exempt from Section 16(b) of the Securities Exchange Act of 1934 by virtue of Rule 16b-3 promulgated thereunder, as it was approved by the Issuer's Board of Directors. The warrants are fully vested.

F1 · price: The grant of the Issuer's warrants was exempt from Section 16(b) of the Securities Exchange Act of 1934 by virtue of Rule 16b-3 promulgated thereunder, as it was approved by the Issuer's Board of Directors. The warrants are fully vested.

F2 · ownership.nature: TBF Holdings LLC is an entity which the Reporting Person controls.

Read SEC document
March 20, 2025 Filed Oct 15, 2025 16:16 UTC
Devereux William TChief Financial Officer
GrantStock Options (Right to Buy) · Derivative 15,000 $0.00 Strike: $6.04 $0.00
Disclosure

SEC source: 0001731122-25-001384 · ownership.xml · derivative · entry 1

Devereux William T · CIK 0002089296 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 15,000

Underlying: Common Stock · 15,000 shares

Expires 2030-03-20

F1 · security: The stock options vest as follows: 5,000 are vested, 5,000 vest on March 20, 2026 and 5,000 vest on March 20, 2027, subject in each case to continued services to the Company as of each applicable vesting date.

F2 · security: Gives effect to a reverse stock split of 1-for-40 effective March 27, 2025.

F1 · derivative.exercise_date: The stock options vest as follows: 5,000 are vested, 5,000 vest on March 20, 2026 and 5,000 vest on March 20, 2027, subject in each case to continued services to the Company as of each applicable vesting date.

Read SEC document
April 26, 2024 Filed May 6, 2024 18:22 UTC
Ivancsits Julius PaulChief Financial Officer
GrantStock options · Derivative 750,000 $0.00 Strike: $0.33 $0.00
Disclosure

SEC source: 0001731122-24-000741 · ownership.xml · derivative · entry 1

Ivancsits Julius Paul · CIK 0002022414 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 750,000

Underlying: Common stock · 750,000 shares

Expires 2034-04-26

F1 · derivative.exercise_date: The options are being issued in connection with appointment as the chief financial officer of the Company, pursuant to the 2020 Long-Term Incentive Compensation Plan. 250,000 of the options vested on April 24, 2024, with the remaining options vesting in two equal annual installments beginning on April 24, 2025.

F1 · balance_after: The options are being issued in connection with appointment as the chief financial officer of the Company, pursuant to the 2020 Long-Term Incentive Compensation Plan. 250,000 of the options vested on April 24, 2024, with the remaining options vesting in two equal annual installments beginning on April 24, 2025.

Read SEC document
April 19, 2024 Filed Oct 20, 2025 20:15 UTC GrantStock Options (Right to Buy) · Derivative 15,000 $0.00 Strike: $13.60 $0.00
Disclosure

SEC source: 0001731122-25-001405 · ownership.xml · derivative · entry 2

Caple Frederick William · CIK 0001978199 · Director

10b5-1 filing: No plan indicated

Ownership: Indirect · SNS Universal Solutions LLC

Disclosed balance after: 15,000

Underlying: Common Stock · 15,000 shares

Expires 2027-04-19

F2 · security: The stock options shall be exercisable for a 3-year period, and shall vest as follows: 75,000 immediately (125,000 already vested) and 50,000 per quarter for the next 8 quarters.

F3 · security: Gives effect to a reverse stock split of 1-for-40 effective March 27, 2025.

F1 · derivative.exercise_date: The grant of the Issuer's restricted common stock was exempt from Section 16(b) of the Securities Exchange Act of 1934 by virtue of Rule 16b-3 promulgated thereunder, as it was approved by the Issuer's Board of Directors. The shares of restricted common stock are fully vested.

F4 · ownership.nature: SNS Universal Solutions LLC is an entity which the Reporting Person controls.

Read SEC document
April 19, 2024 Filed Oct 20, 2025 20:15 UTC GrantCommon Stock 1,875 $0.00 $0.00
Disclosure

SEC source: 0001731122-25-001405 · ownership.xml · nonDerivative · entry 1

Caple Frederick William · CIK 0001978199 · Director

10b5-1 filing: No plan indicated

Ownership: Indirect · SNS Universal Solutions LLC

Disclosed balance after: 1,875

F1 · security: The grant of the Issuer's restricted common stock was exempt from Section 16(b) of the Securities Exchange Act of 1934 by virtue of Rule 16b-3 promulgated thereunder, as it was approved by the Issuer's Board of Directors. The shares of restricted common stock are fully vested.

F3 · shares: Gives effect to a reverse stock split of 1-for-40 effective March 27, 2025.

F3 · balance_after: Gives effect to a reverse stock split of 1-for-40 effective March 27, 2025.

F4 · ownership.nature: SNS Universal Solutions LLC is an entity which the Reporting Person controls.

Read SEC document
March 05, 2024 Filed Oct 15, 2025 20:18 UTC
Nistico RobertDirector · CEO and Chairman
GrantCommon Stock 4,000 $0.00 $0.00
Disclosure

SEC source: 0001731122-25-001385 · ownership.xml · nonDerivative · entry 1

Nistico Robert · CIK 0001797597 · Director · CEO and Chairman

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 38,053

F1 · security: The grant of the Issuer's restricted common stock was exempt from Section 16(b) of the Securities Exchange Act of 1934 by virtue of Rule 16b-3 promulgated thereunder, as it was approved by the Issuer's Board of Directors. The shares of restricted common stock are fully vested.

F2 · shares: Gives effect to a reverse stock split of 1-for-40 effective March 27, 2025.

F2 · balance_after: Gives effect to a reverse stock split of 1-for-40 effective March 27, 2025.

F3 · balance_after: The amount beneficially owned will not reconcile to prior Form 4s due to a scriveners error.

Read SEC document
February 26, 2024 Filed Mar 7, 2024 22:30 UTC GrantStock options · Derivative 600,000 $0.00 Strike: $0.53 $0.00
Disclosure

SEC source: 0001731122-24-000375 · ownership.xml · derivative · entry 1

Paglia John Kenneth · CIK 0001627832 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 600,000

Underlying: Common stock · 600,000 shares

Expires 2034-02-26

F1 · kind: The options were issued in connection with serving as a director on SBEV's board, pursuant to the 2020 Long-Term Incentive Compensation Plan. The options are subject to the following vesting schedule: (i) 200,000 shares vested upon execution of Dr. Paglia's offer letter, and (ii) the remaining 400,000 shares vesting 50,000 per quarter beginning May 23, 2024, and ending February 25, 2026. Should there be a change in control of the Company, the options will all immediately vest.

F2 · kind: Dr. Paglia's shares remain subject to termination in the event Dr. Paglia chooses to resign during the first 90 days of his tenure.

F1 · shares: The options were issued in connection with serving as a director on SBEV's board, pursuant to the 2020 Long-Term Incentive Compensation Plan. The options are subject to the following vesting schedule: (i) 200,000 shares vested upon execution of Dr. Paglia's offer letter, and (ii) the remaining 400,000 shares vesting 50,000 per quarter beginning May 23, 2024, and ending February 25, 2026. Should there be a change in control of the Company, the options will all immediately vest.

F2 · shares: Dr. Paglia's shares remain subject to termination in the event Dr. Paglia chooses to resign during the first 90 days of his tenure.

F1 · derivative.exercise_date: The options were issued in connection with serving as a director on SBEV's board, pursuant to the 2020 Long-Term Incentive Compensation Plan. The options are subject to the following vesting schedule: (i) 200,000 shares vested upon execution of Dr. Paglia's offer letter, and (ii) the remaining 400,000 shares vesting 50,000 per quarter beginning May 23, 2024, and ending February 25, 2026. Should there be a change in control of the Company, the options will all immediately vest.

F2 · derivative.expiration_date: Dr. Paglia's shares remain subject to termination in the event Dr. Paglia chooses to resign during the first 90 days of his tenure.

F3 · derivative.expiration_date: The expiration date of the options is fixed at 2/26/2034 and is unaffected whether or not Dr. Paglia is engaged with the Company.

Read SEC document
June 16, 2023 Filed Jun 16, 2023 15:19 UTC
Nistico RobertDirector · CEO and Chairman
PurchaseCommon Stock 7,000 $1.01 $7,070.00
Disclosure

SEC source: 0001731122-23-001152 · ownership.xml · nonDerivative · entry 1

Nistico Robert · CIK 0001797597 · Director · CEO and Chairman

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,386,000

Read SEC document
May 02, 2023 Filed Aug 3, 2023 17:41 UTC
Wall Ronald CharlesChief Financial Officer
GrantStock options · Derivative 222,000 $0.00 Strike: $1.21 $0.00
Disclosure

SEC source: 0001731122-23-001343 · ownership.xml · derivative · entry 1

Wall Ronald Charles · CIK 0001925305 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 333,000

Underlying: Common stock · 222,000 shares

Expires 2033-05-02

F1 · derivative.exercise_date: The options are being issued in connection with serving as the chief financial officer of SBEV, pursuant to the 2020 Long-Term Incentive Compensation Plan. 166,500 of the options vested on May 2, 2023 and 55,500 options will vest on May 2, 2024.

Read SEC document
May 01, 2023 Filed May 19, 2023 18:06 UTC GrantStock options · Derivative 125,000 $0.00 Strike: $1.26 $0.00
Disclosure

SEC source: 0001731122-23-000987 · ownership.xml · derivative · entry 1

Caple Frederick William · CIK 0001978199 · Director

10b5-1 filing: No plan indicated

Ownership: Indirect · By SNS Universal Solutions, LLC

Disclosed balance after: 125,000

Underlying: Common stock · 125,000 shares

Expires 2033-05-01

F1 · derivative.exercise_date: The options are being issued in connection with serving on the board of directors of SBEV, pursuant to the 2020 Long-Term Incentive Compensation Plan. 10,417 options will vest on the 1st day of each month starting June 2023 until January 2024 and 10,416 options will vest on the 1st day of each month starting February 2024 until May 2024.

F2 · ownership.nature: The Stock Options are issued to SNS Universal Solutions, LLC of which Frederick William Caple is the principle.

Read SEC document
April 24, 2023 Filed May 15, 2023 16:30 UTC GrantStock options · Derivative 125,000 $0.00 Strike: $1.12 $0.00
Disclosure

SEC source: 0001731122-23-000934 · ownership.xml · derivative · entry 1

Crawford Candace · CIK 0001864097 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 125,000

Underlying: Common stock · 125,000 shares

Expires 2033-04-05

F1 · derivative.exercise_date: The options are being issued in connection with serving on the board of directors of SBEV, pursuant to the 2020 Long-Term Incentive Compensation Plan. 10,417 options will vest on the 5th day of each month starting May 2023 until December 2023 and 10,416 options will vest on the 5th day of each month starting January 2024 until April 2024.

Read SEC document
April 24, 2023 Filed May 15, 2023 20:30 UTC GrantStock options · Derivative 125,000 $0.00 Strike: $1.12 $0.00
Disclosure

SEC source: 0001731122-23-000935 · ownership.xml · derivative · entry 1

Yorke Justin W · CIK 0001361896 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 125,000

Underlying: Common stock · 125,000 shares

Expires 2033-04-05

F1 · derivative.exercise_date: The options are being issued in connection with serving on the board of directors of SBEV, pursuant to the 2020 Long-Term Incentive Compensation Plan. 10,417 options will vest on the 5th day of each month starting May 2023 until December 2023 and 10,416 options will vest on the 5th day of each month starting January 2024 until April 2024.

Read SEC document
April 24, 2023 Filed May 15, 2023 20:31 UTC GrantStock options · Derivative 125,000 $0.00 Strike: $1.12 $0.00
Disclosure

SEC source: 0001731122-23-000936 · ownership.xml · derivative · entry 1

McDonough Peter J · CIK 0001680728 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 125,000

Underlying: Common stock · 125,000 shares

Expires 2033-04-05

F1 · derivative.exercise_date: The options are being issued in connection with serving on the board of directors of SBEV, pursuant to the 2020 Long-Term Incentive Compensation Plan. 10,417 options will vest on the 5th day of each month starting May 2023 until December 2023 and 10,416 options will vest on the 5th day of each month starting January 2024 until April 2024.

Read SEC document
April 14, 2023 Filed Apr 14, 2023 14:34 UTC
Nistico RobertDirector · CEO and Chairman
PurchaseCommon Stock 12,000 $1.15 $13,788.00
Disclosure

SEC source: 0001731122-23-000653 · ownership.xml · nonDerivative · entry 1

Nistico Robert · CIK 0001797597 · Director · CEO and Chairman

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,379,000

Read SEC document
April 13, 2023 Filed Apr 13, 2023 16:48 UTC
Nistico RobertDirector · CEO and Chairman
PurchaseCommon Stock 10,000 $1.17 $11,699.00
Disclosure

SEC source: 0001731122-23-000644 · ownership.xml · nonDerivative · entry 2

Nistico Robert · CIK 0001797597 · Director · CEO and Chairman

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,367,000

Read SEC document
April 13, 2023 Filed Apr 13, 2023 16:48 UTC
Nistico RobertDirector · CEO and Chairman
PurchaseCommon Stock 7,000 $1.17 $8,183.00
Disclosure

SEC source: 0001731122-23-000644 · ownership.xml · nonDerivative · entry 1

Nistico Robert · CIK 0001797597 · Director · CEO and Chairman

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,357,000

Read SEC document
June 16, 2022 Filed Jun 16, 2022 21:04 UTC
Nistico RobertDirector · CEO and Chairman
PurchaseCommon Stock 1,000 $1.69 $1,690.00
Disclosure

SEC source: 0001731122-22-001089 · ownership.xml · nonDerivative · entry 5

Nistico Robert · CIK 0001797597 · Director · CEO and Chairman

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,327,070

Read SEC document
June 16, 2022 Filed Jun 16, 2022 21:04 UTC
Nistico RobertDirector · CEO and Chairman
PurchaseCommon Stock 1,000 $1.67 $1,670.00
Disclosure

SEC source: 0001731122-22-001089 · ownership.xml · nonDerivative · entry 4

Nistico Robert · CIK 0001797597 · Director · CEO and Chairman

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,326,070

Read SEC document
June 16, 2022 Filed Jun 16, 2022 21:04 UTC
Nistico RobertDirector · CEO and Chairman
PurchaseCommon Stock 1,000 $1.69 $1,690.00
Disclosure

SEC source: 0001731122-22-001089 · ownership.xml · nonDerivative · entry 3

Nistico Robert · CIK 0001797597 · Director · CEO and Chairman

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,325,070

Read SEC document
June 15, 2022 Filed Jun 16, 2022 21:04 UTC
Nistico RobertDirector · CEO and Chairman
PurchaseCommon Stock 685 $1.83 $1,253.55
Disclosure

SEC source: 0001731122-22-001089 · ownership.xml · nonDerivative · entry 2

Nistico Robert · CIK 0001797597 · Director · CEO and Chairman

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,324,070

Read SEC document
June 15, 2022 Filed Jun 16, 2022 21:04 UTC
Nistico RobertDirector · CEO and Chairman
PurchaseCommon Stock 315 $1.82 $573.30
Disclosure

SEC source: 0001731122-22-001089 · ownership.xml · nonDerivative · entry 1

Nistico Robert · CIK 0001797597 · Director · CEO and Chairman

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,323,385

Read SEC document
June 03, 2022 Filed Jun 7, 2022 13:09 UTC
Nistico RobertDirector · CEO and Chairman
PurchaseCommon Stock 1,000 $2.07 $2,070.00
Disclosure

SEC source: 0001731122-22-001037 · ownership.xml · nonDerivative · entry 2

Nistico Robert · CIK 0001797597 · Director · CEO and Chairman

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,323,070

Read SEC document
June 03, 2022 Filed Jun 7, 2022 13:09 UTC
Nistico RobertDirector · CEO and Chairman
PurchaseCommon Stock 1,000 $2.04 $2,040.00
Disclosure

SEC source: 0001731122-22-001037 · ownership.xml · nonDerivative · entry 1

Nistico Robert · CIK 0001797597 · Director · CEO and Chairman

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,322,070

Read SEC document
May 27, 2022 Filed May 31, 2022 20:05 UTC
Nistico RobertDirector · CEO and Chairman
PurchaseCommon Stock 1,000 $2.04 $2,040.00
Disclosure

SEC source: 0001731122-22-001019 · ownership.xml · nonDerivative · entry 7

Nistico Robert · CIK 0001797597 · Director · CEO and Chairman

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,321,070

Read SEC document
May 27, 2022 Filed May 31, 2022 20:05 UTC
Nistico RobertDirector · CEO and Chairman
PurchaseCommon Stock 1,000 $2.03 $2,030.00
Disclosure

SEC source: 0001731122-22-001019 · ownership.xml · nonDerivative · entry 6

Nistico Robert · CIK 0001797597 · Director · CEO and Chairman

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,320,070

Read SEC document
May 27, 2022 Filed May 31, 2022 20:05 UTC
Nistico RobertDirector · CEO and Chairman
PurchaseCommon Stock 2,000 $2.12 $4,240.00
Disclosure

SEC source: 0001731122-22-001019 · ownership.xml · nonDerivative · entry 5

Nistico Robert · CIK 0001797597 · Director · CEO and Chairman

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,319,070

Read SEC document
May 26, 2022 Filed May 31, 2022 20:05 UTC
Nistico RobertDirector · CEO and Chairman
PurchaseCommon Stock 2,000 $1.95 $3,900.00
Disclosure

SEC source: 0001731122-22-001019 · ownership.xml · nonDerivative · entry 4

Nistico Robert · CIK 0001797597 · Director · CEO and Chairman

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,317,070

Read SEC document
May 26, 2022 Filed May 31, 2022 20:05 UTC
Nistico RobertDirector · CEO and Chairman
PurchaseCommon Stock 2,000 $1.95 $3,900.00
Disclosure

SEC source: 0001731122-22-001019 · ownership.xml · nonDerivative · entry 3

Nistico Robert · CIK 0001797597 · Director · CEO and Chairman

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,315,070

Read SEC document
May 26, 2022 Filed May 31, 2022 20:05 UTC
Nistico RobertDirector · CEO and Chairman
PurchaseCommon Stock 2,000 $1.99 $3,980.00
Disclosure

SEC source: 0001731122-22-001019 · ownership.xml · nonDerivative · entry 2

Nistico Robert · CIK 0001797597 · Director · CEO and Chairman

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,313,070

Read SEC document
May 26, 2022 Filed May 31, 2022 20:05 UTC
Nistico RobertDirector · CEO and Chairman
PurchaseCommon Stock 1,000 $1.94 $1,940.00
Disclosure

SEC source: 0001731122-22-001019 · ownership.xml · nonDerivative · entry 1

Nistico Robert · CIK 0001797597 · Director · CEO and Chairman

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,311,070

Read SEC document
May 02, 2022 Filed Jan 31, 2023 20:18 UTC
Wall Ronald CharlesChief Financial Officer
GrantOption (Right to Buy) · Derivative 111,000 $0.00 Strike: $2.31 $0.00
Disclosure

SEC source: 0001731122-23-000105 · ownership.xml · derivative · entry 1

Wall Ronald Charles · CIK 0001925305 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 111,000

Underlying: Common Stock · 111,000 shares

Expires 2032-05-02

F1 · derivative.exercise_date: One-fourth of the Options vested on May 2, 2022. One-fourth of the Options will vest on May 2, 2023, May 2, 2024, and May 2, 2025.

Read SEC document
May 02, 2022 Filed Oct 16, 2023 21:54 UTC
Dhalla FatimaInterim CFO
GrantStock options · Derivative 35,000 $0.00 Strike: $1.12 $0.00
Disclosure

SEC source: 0001731122-23-001907 · ownership.xml · derivative · entry 1

Dhalla Fatima · CIK 0001913908 · Interim CFO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 35,000

Underlying: Common stock · 35,000 shares

Expires 2032-05-02

F1 · derivative.exercise_date: The options were issued in connection with serving as the interim chief financial officer of SBEV, pursuant to the 2020 Long-Term Incentive Compensation Plan. All 35,000 options vested on May 2, 2022.

Read SEC document
September 30, 2021 Filed Mar 31, 2022 21:44 UTC GrantOption (Right to Buy) · Derivative 125,000 $0.00 Strike: $2.60 $0.00
Disclosure

SEC source: 0001731122-22-000657 · ownership.xml · derivative · entry 1

Crawford Candace · CIK 0001864097 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 125,000

Underlying: Common Stock · 125,000 shares

Expires 2026-09-30

F1 · derivative.exercise_date: Two-thirds of the Options vested on September 30, 2021, and one-third of the Options vest on September 30, 2022.

Read SEC document
September 30, 2021 Filed Apr 1, 2022 01:42 UTC GrantOption (Right to Buy) · Derivative 125,000 $0.00 Strike: $2.60 $0.00
Disclosure

SEC source: 0001731122-22-000655 · ownership.xml · derivative · entry 1

Yorke Justin W · CIK 0001361896 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 125,000

Underlying: Common Stock · 125,000 shares

Expires 2026-09-30

F1 · derivative.exercise_date: Two-thirds of the Options vested on September 30, 2021, and one-third of the Options vest on September 30, 2022.

Read SEC document
September 30, 2021 Filed Apr 1, 2022 01:39 UTC
Nistico RobertDirector · CEO, President and Chairman
GrantOption (Right to Buy) · Derivative 530,000 $0.00 Strike: $2.60 $0.00
Disclosure

SEC source: 0001731122-22-000653 · ownership.xml · derivative · entry 1

Nistico Robert · CIK 0001797597 · Director · CEO, President and Chairman

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 530,000

Underlying: Common Stock · 530,000 shares

Expires 2026-09-30

F1 · derivative.exercise_date: Two-thirds of the Options vested on September 30, 2021, and one-third of the Options vest on September 30, 2022.

Read SEC document
September 30, 2021 Filed Apr 1, 2022 01:37 UTC GrantOption (Right to Buy) · Derivative 125,000 $0.00 Strike: $2.60 $0.00
Disclosure

SEC source: 0001731122-22-000651 · ownership.xml · derivative · entry 1

McDonough Peter J · CIK 0001680728 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 125,000

Underlying: Common Stock · 125,000 shares

Expires 2026-09-30

F1 · derivative.exercise_date: Two-thirds of the Options vested on September 30, 2021, and one-third of the Options vest on September 30, 2022.

Read SEC document
May 16, 2021 Filed Apr 5, 2022 17:25 UTC GrantOption (Right to Buy) · Derivative 333,333 $0.00 Strike: $2.25 $0.00
Disclosure

SEC source: 0001731122-22-000676 · ownership.xml · derivative · entry 1

Crawford Candace · CIK 0001864097 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 333,333

Underlying: Common Stock · 333,333 shares

Expires 2026-05-15

F1 · derivative.exercise_date: One-third of the Options vested immediately, one-third of the Options vested on May 15, 2021, and one-third of the Options vest on May 15, 2022.

Read SEC document
October 16, 2020 Filed Oct 19, 2020 22:30 UTC GrantWarrants (Right to Buy) · Derivative 166,666 Not disclosed Strike: $0.75 Not disclosed
Disclosure

SEC source: 0001731122-20-001059 · ownership.xml · derivative · entry 3

Yorke Justin W · CIK 0001361896 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 166,666

Underlying: Common Stock · 166,666 shares

Expires 2027-10-15

F1 · price: Not applicable

Read SEC document
October 16, 2020 Filed Oct 19, 2020 22:30 UTC GrantWarrants (Right to Buy) · Derivative 166,667 Not disclosed Strike: $0.75 Not disclosed
Disclosure

SEC source: 0001731122-20-001059 · ownership.xml · derivative · entry 2

Yorke Justin W · CIK 0001361896 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 166,667

Underlying: Common Stock · 166,667 shares

Expires 2026-10-15

F1 · price: Not applicable

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.